Limba
|
Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selective AKT pathwayinhibitor exhibiting a manageable safety profile among patients with advanced solid tumors.
| Price | 8.142,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Miransertib (ARQ 092) HCl is a novel, orally bioavailable and selective AKT pathwayinhibitor exhibiting a manageable safety profile among patients with advanced solid tumors. |